tiprankstipranks
Synlogic (SYBX)
NASDAQ:SYBX
Holding SYBX?
Track your performance easily

Synlogic (SYBX) Stock Price & Analysis

567 Followers

SYBX Stock Chart & Stats


Financials

Annual

Ownership Overview

15.33%2.79%<0.01%80.33%
15.33% Insiders
<0.01% Other Institutional Investors
80.33% Public Companies and Individual Investors

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

SYBX FAQ

What was Synlogic’s price range in the past 12 months?
Synlogic lowest stock price was $1.22 and its highest was $3.73 in the past 12 months.
    What is Synlogic’s market cap?
    Synlogic’s market cap is $16.96M.
      When is Synlogic’s upcoming earnings report date?
      Synlogic’s upcoming earnings report date is Mar 13, 2025 which is in 54 days.
        How were Synlogic’s earnings last quarter?
        Synlogic released its earnings results on Nov 12, 2024. The company reported -$0.01 earnings per share for the quarter, beating the consensus estimate of -$0.18 by $0.17.
          Is Synlogic overvalued?
          According to Wall Street analysts Synlogic’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Synlogic pay dividends?
            Synlogic does not currently pay dividends.
            What is Synlogic’s EPS estimate?
            Synlogic’s EPS estimate is -0.1.
              How many shares outstanding does Synlogic have?
              Synlogic has 11,696,109 shares outstanding.
                What happened to Synlogic’s price movement after its last earnings report?
                Synlogic reported an EPS of -$0.01 in its last earnings report, beating expectations of -$0.18. Following the earnings report the stock price went down -3.425%.
                  Which hedge fund is a major shareholder of Synlogic?
                  Among the largest hedge funds holding Synlogic’s share is RA Capital Management. It holds Synlogic’s shares valued at 0.
                    ---

                    Company Description

                    Synlogic

                    Synlogic, Inc. is a clinical-stage biopharmaceutical company, which engages in drug discovery and development of synthetic biotic medicines. It focuses on SYNB1020 and SYNB1618, which are orally administered and target hyperammonemia and phenylketonuria. It also works on SYNB1891, an intratumorally administered which treats cancer. The company was founded by Jim Collins and Tim Lu on August 28, 2017, and is headquartered in Cambridge, MA.
                    ---
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    ADMA Biologics
                    Agenus
                    Adaptimmune Therapeutics
                    Aclaris Therapeutics
                    Akari Therapeutics
                    Aldeyra Therapeutics
                    Popular Stocks
                    ---
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis